SAVA - Cassava Sciences, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
68,032
68,032
24,813
3,053
1,568
Selling general and administrative
11,988
11,988
8,055
3,739
3,391
Total operating expenses
80,020
80,020
32,868
6,792
4,959
Operating income or loss
-80,020
-80,020
-32,868
-6,792
-4,959
Total other income/expenses net
997
997
434
346
-
Income before tax
-76,246
-76,246
-32,385
-6,334
-4,631
Income from continuing operations
-76,246
-76,246
-32,385
-6,334
-4,631
Net income
-76,246
-76,246
-32,385
-6,334
-4,631
Net income available to common shareholders
-76,246
-76,246
-32,385
-6,334
-4,631
Basic EPS
-
-1.90
-0.82
-0.24
-0.27
Diluted EPS
-
-1.90
-0.82
-0.24
-0.27
Basic average shares
-
40,202
39,405
26,105
17,412
Diluted average shares
-
40,202
39,405
26,105
17,412
EBITDA
-
-80,020
-32,868
-6,792
-4,959